ヒトオルガノイドの世界市場レポート 2025年

ヒトオルガノイド市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR16.5％で31億5,000万米ドルに成長します。予測期間中の成長は、オルガノイドベースの疾患モデリングに対する需要の高まり、バイオテクノロジー研究への投資の増加、薬剤スクリーニングにおける用途の拡大、毒物学研究における採用の拡大、精密医療への関心の高まりに起因しています。予測期間における主な動向には、人工知能の統合、患者特異的オルガノイドの開発、遺伝子治療アプリケーションへの拡大、オルガノイドバイオプリンティングの進歩、3D細胞培養の技術進歩などがあります。

遺伝子研究実験の増加は、調査市場の成長を牽引すると予想されます。遺伝子を介して形質がどのように受け継がれるのか、遺伝情報が生物の開発と機能にどのように影響するのかに焦点を当てる遺伝子科学は、遺伝子編集をより迅速かつ正確に行う技術の進歩により、実験件数が増加しています。このような画期的な進歩により、病気に対するより深い研究や、的を絞った治療法の開発が可能になります。ヒトオルガノイドの文脈では、遺伝子科学は、特定の疾患をモデル化し、その進行を研究するために遺伝子を正確に操作することを可能にします。これは、研究者が遺伝子疾患をよりよく理解し、新薬をテストし、個別化された治療戦略を探求するのに役立ちます。例えば、2023年4月、米国の医学研究機関である国立衛生研究所（NIH）の報告書によると、2022年11月までに米国では12万9,624件の遺伝子検査が登録され、全世界の遺伝子検査登録（GTR）に登録されている全検査の約66％を占めています。このように、遺伝子調査実験件数の増加は、ヒトオルガノイド市場の成長に貢献します。

ヒトオルガノイド市場の主要企業は、in vitroモデルの生理学的妥当性を高めるため、次世代3D組織培養プラットフォームなどの先進幹細胞技術の開発に注力しています。次世代3D組織培養プラットフォームとは、従来の2Dやそれ以前の3Dモデルと比較して、ヒト組織の複雑性をより正確に再現するように設計された先進的な体外システムです。例えば、2022年10月、AIM Biotech Pte.Ltd.は、先進的な3D組織培養システムであるorganiXを発表しました。このシステムは、オルガノイド、機能的血管系、免疫細胞成分を統合することで、ヒトの疾患状態をより正確に再現するように設計されています。このプラットフォームは、最先端の医薬品開発と個別化医療のために調整されており、制御可能で生理学的に適切な環境内で、オルガノイドや腫瘍サンプルなどの様々な組織フォーマットに対応します。免疫共培養をサポートし、リアルタイムの高解像度イメージングを可能にし、下流分析のための組織回収を容易にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ヒトオルガノイド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヒトオルガノイド市場：成長率分析
• 世界のヒトオルガノイド市場の実績：規模と成長, 2019-2024
• 世界のヒトオルガノイド市場の予測：規模と成長, 2024-2029, 2034F
• 世界ヒトオルガノイド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒトオルガノイド市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳オルガノイド
• 心臓オルガノイド
• 腸管オルガノイド
• 腎臓オルガノイド
• 肝臓オルガノイド
• 肺オルガノイド
• 膵臓オルガノイド
• 世界のヒトオルガノイド市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 3Dバイオプリンティング
• 細胞培養技術
• ハイドロゲルと足場ベースの技術
• 磁気浮上
• 世界のヒトオルガノイド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 創薬
• 感染症調査
• 神経学研究
• 腫瘍調査
• パーソナライズ医療
• 再生医療
• 世界のヒトオルガノイド市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• 学術研究機関
• 世界のヒトオルガノイド市場脳オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳オルガノイド
• 中脳オルガノイド
• 視床下部オルガノイド
• 脊髄オルガノイド
• 世界のヒトオルガノイド市場心臓オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心筋オルガノイド
• 血管化心臓オルガノイド
• 心室特異的心臓オルガノイド
• 世界のヒトオルガノイド市場腸管オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小腸オルガノイド
• 結腸オルガノイド
• 十二指腸オルガノイド
• 世界のヒトオルガノイド市場腎臓オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ネフロンオルガノイド
• 糸球体オルガノイド
• 近位尿細管オルガノイド
• 世界のヒトオルガノイド市場肝臓オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝臓オルガノイド
• 胆管オルガノイド
• 胆管細胞オルガノイド
• 世界のヒトオルガノイド市場肺オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 気道オルガノイド
• 肺胞オルガノイド
• 気管支オルガノイド
• 世界のヒトオルガノイド市場膵臓オルガノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 膵島オルガノイド
• 管状膵臓オルガノイド
• 腺房膵臓オルガノイド

第7章 地域別・国別分析

• 世界のヒトオルガノイド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のヒトオルガノイド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒトオルガノイド市場：競合情勢
• ヒトオルガノイド市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Emulate Inc.
• MIMETAS B.V.
• Cellink AB
• InSphero AG
• Kerafast Inc.
• DefiniGEN Limited
• Visikol Inc.
• CN Bio Innovations Limited
• Cannex Scientific Inc.
• HeartBeat.bio AG
• Kirkstall Ltd.
• Cyprio Ltd.
• 3Dnamics Inc.
• BrainZell Ltd.
• AIVITA Biomedical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒトオルガノイド市場2029：新たな機会を提供する国
• ヒトオルガノイド市場2029：新たな機会を提供するセグメント
• ヒトオルガノイド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Human organoids are powerful models for studying human biology, disease mechanisms, and testing drug responses in ways that mimic real human organs. The main types of human organoids, such as brain, heart, intestinal, kidney, liver, lung, and pancreatic organoids, allow researchers to investigate specific organ-related diseases and conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Brain organoids, for instance, are used in drug discovery, neurology studies, infectious disease research, oncology research, and personalized medicine. These organoids are created using cutting-edge technologies, such as 3D bioprinting, hydrogels, scaffold-based methods, and magnetic levitation, which help replicate the three-dimensional structure and function of human tissues. The primary users of these organoids include pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic research institutions, which use these models for various applications ranging from disease modeling to drug testing and personalized therapeutic development.

The human organoids market research report is one of a series of new reports from The Business Research Company that provides human organoids market statistics, including human organoids industry global market size, regional shares, competitors with a human organoids market share, detailed human organoids market segments, market trends and opportunities, and any further data you may need to thrive in the human organoids industry. This human organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human organoids market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth during the historic period can be attributed to a greater emphasis on personalized medicine, the rising prevalence of chronic diseases, advancements in regenerative medicine, the expansion of drug discovery applications, and the increase in government and private sector funding.

The human organoids market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth during the forecast period can be attributed to the rising demand for organoid-based disease modeling, increased investment in biotech research, expanding uses in drug screening, greater adoption in toxicology studies, and growing interest in precision medicine. Key trends in the forecast period include the integration of artificial intelligence, the development of patient-specific organoids, expansion into gene therapy applications, advancements in organoid bioprinting, and technological progress in 3D cell culture.

The growing number of genetic research experiments is expected to drive the growth of the human organoids market. Genetic science, which focuses on how traits are inherited through genes and how genetic information influences the development and functioning of organisms, is seeing an increase in experiments due to technological advancements that make gene editing faster and more accurate. These breakthroughs enable deeper research into diseases and the development of targeted treatments. In the context of human organoids, genetic science allows for precise manipulation of genes to model specific diseases and study their progression. This helps researchers better understand genetic disorders, test new drugs, and explore personalized treatment strategies. For example, in April 2023, a report by the National Institutes of Health (NIH), a US-based medical research agency, noted that by November 2022, the U.S. had registered 129,624 genetic tests, accounting for approximately 66% of all tests in the worldwide Genetic Testing Registry (GTR). As such, the rising number of genetic research experiments will contribute to the growth of the human organoids market.

Leading companies in the human organoids market are focusing on developing advanced stem cell technologies, such as next-generation 3D tissue culture platforms, to enhance the physiological relevance of in vitro models. A next-generation 3D tissue culture platform is an advanced in vitro system designed to more accurately replicate the complexity of human tissues compared to traditional 2D or earlier 3D models. For instance, in October 2022, AIM Biotech Pte. Ltd., a Singapore-based developer of tissue culture chips, introduced organiX, an advanced 3D tissue culture system. This system is designed to more accurately replicate human disease conditions by integrating organoids, functional vasculature, and immune cell components. The platform is tailored for cutting-edge drug development and personalized medicine, accommodating various tissue formats, such as organoids and tumor samples, within a controllable and physiologically relevant environment. It supports immune co-culture, allows real-time high-resolution imaging, and facilitates easy tissue retrieval for downstream analyses.

In January 2025, Merck Group, a Germany-based pharmaceutical company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to bolster Merck's next-generation biology portfolio by incorporating advanced organoid technology. This will accelerate drug development, provide deeper insights into treatments across various populations, and reduce the need for animal testing, aligning with Merck's commitment to innovative and ethical life sciences solutions. HUB Organoids Holding B.V., based in the Netherlands, specializes in human organoid research and applications.

Major players in the human organoids market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Corning Incorporated, Bio-Techne Corporation, Organovo Holdings Inc., Emulate Inc., MIMETAS B.V., Cellink AB, InSphero AG, Kerafast Inc., DefiniGEN Limited, Visikol Inc., CN Bio Innovations Limited, Cannex Scientific Inc., HeartBeat.bio AG, Kirkstall Ltd., Cyprio Ltd., 3Dnamics Inc., BrainZell Ltd., AIVITA Biomedical Inc.

North America was the largest region in the human organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human organoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human organoids market include revenues earned by entities by providing services such as drug discovery and development, disease modeling, toxicology testing, regenerative medicine research, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. The human organoids market also consists of sales of products including organoid-based therapeutics, disease modeling solutions, drug testing platforms, and research applications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Organoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human organoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human organoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Brain Organoids; Heart Organoids; Intestinal Organoids; Kidney Organoids; Liver Organoids; Lung Organoids; Pancreatic Organoids
• 2) By Technology: 3D Bioprinting; Cell Culture Technology; Hydrogels And Scaffold-Based Technology; Magnetic Levitation
• 3) By Application: Drug Discovery; Infectious Disease Research; Neurology Studies; Oncology Research; Personalized Medicine; Regenerative Medicine
• 4) By End User: Pharma And Biotech Companies; Contract Research Organizations; Academic And Research Institutes
• Subsegments:
• 1) By Brain Organoids: Cerebral Organoids; Midbrain Organoids; Hypothalamic Organoids; Spinal Cord Organoids
• 2) By Heart Organoids: Cardiac Muscle Organoids; Vascularized Heart Organoids; Chamber-Specific Heart Organoids
• 3) By Intestinal Organoids: Small Intestine Organoids; Colon Organoids; Duodenal Organoids
• 4) By Kidney Organoids: Nephron Organoids; Glomerular Organoids; Proximal Tubule Organoids
• 5) By Liver Organoids: Hepatic Organoids; Bile Duct Organoids; Cholangiocyte Organoids
• 6) By Lung Organoids: Airway Organoids; Alveolar Organoids; Bronchial Organoids
• 7) By Pancreatic Organoids: Islet Organoids; Ductal Pancreatic Organoids; Acinar Pancreatic Organoids
• Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Corning Incorporated; Bio-Techne Corporation; Organovo Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Organoids Market Characteristics

3. Human Organoids Market Trends And Strategies

4. Human Organoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Organoids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Human Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Human Organoids Market Growth Rate Analysis
• 5.4. Global Human Organoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Human Organoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Human Organoids Total Addressable Market (TAM)

6. Human Organoids Market Segmentation

• 6.1. Global Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brain Organoids
• Heart Organoids
• Intestinal Organoids
• Kidney Organoids
• Liver Organoids
• Lung Organoids
• Pancreatic Organoids
• 6.2. Global Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3D Bioprinting
• Cell Culture Technology
• Hydrogels And Scaffold-Based Technology
• Magnetic Levitation
• 6.3. Global Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Infectious Disease Research
• Neurology Studies
• Oncology Research
• Personalized Medicine
• Regenerative Medicine
• 6.4. Global Human Organoids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharma And Biotech Companies
• Contract Research Organizations
• Academic And Research Institutes
• 6.5. Global Human Organoids Market, Sub-Segmentation Of Brain Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cerebral Organoids
• Midbrain Organoids
• Hypothalamic Organoids
• Spinal Cord Organoids
• 6.6. Global Human Organoids Market, Sub-Segmentation Of Heart Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Muscle Organoids
• Vascularized Heart Organoids
• Chamber-Specific Heart Organoids
• 6.7. Global Human Organoids Market, Sub-Segmentation Of Intestinal Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Intestine Organoids
• Colon Organoids
• Duodenal Organoids
• 6.8. Global Human Organoids Market, Sub-Segmentation Of Kidney Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nephron Organoids
• Glomerular Organoids
• Proximal Tubule Organoids
• 6.9. Global Human Organoids Market, Sub-Segmentation Of Liver Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatic Organoids
• Bile Duct Organoids
• Cholangiocyte Organoids
• 6.10. Global Human Organoids Market, Sub-Segmentation Of Lung Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Airway Organoids
• Alveolar Organoids
• Bronchial Organoids
• 6.11. Global Human Organoids Market, Sub-Segmentation Of Pancreatic Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Islet Organoids
• Ductal Pancreatic Organoids
• Acinar Pancreatic Organoids

7. Human Organoids Market Regional And Country Analysis

• 7.1. Global Human Organoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Human Organoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Organoids Market

• 8.1. Asia-Pacific Human Organoids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Organoids Market

• 9.1. China Human Organoids Market Overview
• 9.2. China Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Organoids Market

• 10.1. India Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Organoids Market

• 11.1. Japan Human Organoids Market Overview
• 11.2. Japan Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Organoids Market

• 12.1. Australia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Organoids Market

• 13.1. Indonesia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Organoids Market

• 14.1. South Korea Human Organoids Market Overview
• 14.2. South Korea Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Organoids Market

• 15.1. Western Europe Human Organoids Market Overview
• 15.2. Western Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Organoids Market

• 16.1. UK Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Organoids Market

• 17.1. Germany Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Organoids Market

• 18.1. France Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Organoids Market

• 19.1. Italy Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Organoids Market

• 20.1. Spain Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Organoids Market

• 21.1. Eastern Europe Human Organoids Market Overview
• 21.2. Eastern Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Organoids Market

• 22.1. Russia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Organoids Market

• 23.1. North America Human Organoids Market Overview
• 23.2. North America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Organoids Market

• 24.1. USA Human Organoids Market Overview
• 24.2. USA Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Organoids Market

• 25.1. Canada Human Organoids Market Overview
• 25.2. Canada Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Organoids Market

• 26.1. South America Human Organoids Market Overview
• 26.2. South America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Organoids Market

• 27.1. Brazil Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Organoids Market

• 28.1. Middle East Human Organoids Market Overview
• 28.2. Middle East Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Organoids Market

• 29.1. Africa Human Organoids Market Overview
• 29.2. Africa Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Organoids Market Competitive Landscape And Company Profiles

• 30.1. Human Organoids Market Competitive Landscape
• 30.2. Human Organoids Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Organoids Market Other Major And Innovative Companies

• 31.1. Emulate Inc.
• 31.2. MIMETAS B.V.
• 31.3. Cellink AB
• 31.4. InSphero AG
• 31.5. Kerafast Inc.
• 31.6. DefiniGEN Limited
• 31.7. Visikol Inc.
• 31.8. CN Bio Innovations Limited
• 31.9. Cannex Scientific Inc.
• 31.10. HeartBeat.bio AG
• 31.11. Kirkstall Ltd.
• 31.12. Cyprio Ltd.
• 31.13. 3Dnamics Inc.
• 31.14. BrainZell Ltd.
• 31.15. AIVITA Biomedical Inc.

32. Global Human Organoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Organoids Market

34. Recent Developments In The Human Organoids Market

35. Human Organoids Market High Potential Countries, Segments and Strategies

• 35.1 Human Organoids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Human Organoids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Human Organoids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34873_Human_Organoids_GMR_2025